A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis

Clinical trial NCT03165435 · WITHDRAWN

Trial details

NCT number: NCT03165435
Sponsor: CuraVac
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myasthenia Gravis, Generalized

Start date: 2018-07-01
Primary completion: 2019-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.